• [[ Webinar]] Early Phase Insights on Complex Studies and Patient-Centricity

    laureng Whitepapers April 17, 2018
  • Choosing the Right Channel Strategy for Specialty Product Success

    Karina Kusova Clinical Development, Market Access, Orphan Drug Congress, Supply Chain & Manufacturing, Uncategorized, Whitepapers May 3, 2017
  • [Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

    Karina Kusova Clinical Development, Orphan Drug Congress, Uncategorized, Whitepapers April 10, 2017
  • [[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches

    Karina Kusova Clinical Development, Featured on App, Orphan Drug Congress, Uncategorized, Whitepapers April 6, 2017
  • What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)

    Karina Kusova Advocacy, Clinical Development, Market Access, Orphan Drug Congress, Orphan Drugs Live October 10, 2016
  • Accelerating Commercialization of Rare Disease Treatments

    Paul Gilbertson Market Access, Orphan Drug Congress September 1, 2016

Subscribe to Total Orphan Drugs

Strategy and innovation in the orphan drugs and rare diseases industry
Navigation
  • Development
  • Regulation
  • Advocacy
  • Market Access
  • Partnering & Investment
  • Whitepapers
  • Events
    • USA
  • Search
Posts by “wingyun”

Revealing Pfizer’s Collaborative Strategies at the 5th World Orphan Drug Congress

In Orphan Drug Congress, Partnering & Investment by wingyunSeptember 16, 2014Leave a Comment

With the 5th World Orphan Drug Congress on 12- 14 November in Brussels less than two months away, I conducted an interview to one of …

View Post

Exclusive Interview with Dr Jonathan Morton, Oxford PharmaGenesis™ Ltd Speaking at The World Orphan Drug Congress

In Advocacy, Clinical Development, Orphan Drug Congress, Partnering & Investment by wingyunSeptember 9, 2014Leave a Comment

With the 5th World Orphan Drug Congress on 12- 14 November in Brussels only just two months away, I conducted an interview to one of …

View Post

Interview with Nick Sireau, CEO of AKU Society

In Orphan Drug Congress by wingyunAugust 22, 2014Leave a Comment

The 5th World Orphan Drug Congress on 12- 14 November in Brussels is just a couple of months away and I recently sat down with …

View Post

Changing the way we develop orphan drugs – The need of early dialogue

In Orphan Drug Congress by wingyunJuly 18, 2014Leave a Comment

I attended the Fast Tracking Orphan Drugs Terrapinn Briefing in London last week and some interesting common themes were discussed: the nuisance in regulatory unpredictability, …

Categories

  • Advocacy
  • Clinical Development
  • Featured on App
  • Market Access
  • Orphan Drug Congress
  • Orphan Drugs Live
  • Partnering & Investment
  • Press Release
  • Regulation & Government
  • Reports
  • Supply Chain & Manufacturing
  • Uncategorized
  • Whitepapers
Toggle the Widgetbar
World Orphan Drug Congress USA
  • Home
  • About Us/Advertise